Mobile health applications for the management of primary hypertension
Authors:
- Yu-Ling YanYYYu-Ling Yan
- Yu LiYLYu Li
- Jun DuJDJun Du
- Jing WangJWJing Wang
- Yue HanYHYue Han
- Ya ZouYZYa Zou
- Xin-Yu ZouXZXin-Yu Zou
- Hong HuangHHHong Huang
- Qiang SheQSQiang She
Open Access
- 1 April 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (16) , e19715
Abstract
Background: Hypertension is 1 of the major global public health challenges, which means that patients with hypertension need more measures to control their blood pressure. Currently, smart phones and applications are developing rapidly, and mobile health applications are used to manage hypertension, but evidences related to effectiveness are limited. Objective: The purpose was to assess the impact of m-Health apps on blood pressure control, medication adherence. Methods: 480 participants were randomly assigned to the intervention and control groups. The intervention group used the “Yan Fu” app to manage their blood pressure, and the control group did not use any m-Health apps. The outcomes were changes in blood pressure, the percentage of participants with their blood pressure under control and medication adherence. Results: At the end of the study, the baseline characteristics between the 2 groups had no statistically differences (P > .05). Participants in the 2 groups all had lower systolic blood pressure and diastolic blood pressure than they did at baseline, and the intervention group demonstrated a significantly greater systolic blood pressure and diastolic blood pressure reduction than the control group (P < .05). Additionally, the percentage of participants with controlled blood pressure was higher in the intervention group (P < .05). The medication adherence of the intervention group was much higher than that of the control group (P < .05). Conclusion: M-Health apps are effective for hypertension management, it can favor the medication adherence and blood pressure control. Perhaps m-Health apps can be promoted in the blood pressure control. Trial Registration: This study was registered in the Chinese Clinical Trial Registry under the number ChiCTR-IOR-17012069.Keywords
This publication has 10 references indexed in Scilit:
- Chinese Mobile Health APPs for Hypertension Management: A Systematic Evaluation of UsefulnessJournal of Healthcare Engineering, 2018
- Protocol for the mWellcare trial: a multicentre, cluster randomised, 12-month, controlled trial to compare the effectiveness of mWellcare, an mHealth system for an integrated management of patients with hypertension and diabetes, versus enhanced usual care in IndiaBMJ Open, 2017
- Rationale and design of the Medication adherence Improvement Support App For Engagement—Blood Pressure (MedISAFE-BP) trialAmerican Heart Journal, 2017
- Comparing the effectiveness of the BPMAP (Blood Pressure Management Application) and usual care in self-management of primary hypertension and adherence to treatment in patients aged 30–60 years: study protocol for a randomized controlled trialTrials, 2016
- The Influence of Wireless Self-Monitoring Program on the Relationship Between Patient Activation and Health Behaviors, Medication Adherence, and Blood Pressure Levels in Hypertensive Patients: A Substudy of a Randomized Controlled TrialJournal of Medical Internet Research, 2016
- A content analysis of smartphone–based applications for hypertension managementJournal of the American Society of Hypertension, 2015
- Smartphone medication adherence apps: Potential benefits to patients and providersJournal of the American Pharmacists Association, 2013
- A web-based patient activation intervention to improve hypertension care: Study design and baseline characteristics in the web hypertension studyContemporary Clinical Trials, 2010
- Adherence to Long‐Term Therapies: Evidence for ActionJournal of Nursing Scholarship, 2003
- A Clinical Trial of the Effects of Dietary Patterns on Blood PressureNew England Journal of Medicine, 1997